About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Hydrocortisone (except for products indicated in adrenal insufficiency in a modified release tablet formulation)
- Procedure number
- PSUSA/00010328/201908
- Regulatory outcome
- Variation
Documents
Hydrocortisone (except for products indicated in adrenal insufficiency in a modified release tablet formulation): List of nationally authorised medicinal products - PSUSA/00010328/201908
English (EN) (359.53 KB - PDF)
Hydrocortisone (except for products indicated in adrenal insufficiency in a modified release tablet: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010328/201908
English (EN) (81.92 KB - PDF)
български (BG) (86.42 KB - PDF)
español (ES) (90.21 KB - PDF)
čeština (CS) (82.44 KB - PDF)
dansk (DA) (81.99 KB - PDF)
Deutsch (DE) (87.41 KB - PDF)
eesti keel (ET) (89.76 KB - PDF)
ελληνικά (EL) (87.98 KB - PDF)
français (FR) (92.01 KB - PDF)
hrvatski (HR) (89.66 KB - PDF)
íslenska (IS) (82.81 KB - PDF)
italiano (IT) (102.67 KB - PDF)
latviešu valoda (LV) (99.02 KB - PDF)
lietuvių kalba (LT) (90.62 KB - PDF)
magyar (HU) (83.48 KB - PDF)
Malti (MT) (89.05 KB - PDF)
Nederlands (NL) (85.17 KB - PDF)
norsk (NO) (81.08 KB - PDF)
polski (PL) (90.62 KB - PDF)
português (PT) (88.26 KB - PDF)
română (RO) (81.29 KB - PDF)
slovenčina (SK) (91.46 KB - PDF)
slovenščina (SL) (78.75 KB - PDF)
Suomi (FI) (77.12 KB - PDF)
svenska (SV) (79.7 KB - PDF)